Skip to main content
EMAMILTD · Consumer Staples · 2026-08-07

Emami Ltd

Stage 4 · wk 41In scan: Breakout WatchMARKET: BULL TOPPING · 2026-08-07
₹412.6
+0.87% today
₹18,008 Cr · Mid cap
About this companyConsumer Staples· FMCG - Personal Products
Expand ▾

Emami Limited manufactures and markets personal and healthcare products in India and internationally. The company offers antiseptic cream, body lotion, prickly heat powder, petroleum jelly, soaps, aloe vera gel, and all-season cream under the BoroPlus brand; oil and cool talc products under the Navratna brand; and ayurvedic products for pain management, immunity, digestive health, and bone and joint health, as well as healthcare products comprising hair growth vitalizers, skin elixirs, organic apple cider vinegar, cough syrup, herbal tea, health juices, honey, and herb tablets under the Zandu brand. It also provides oils, conditioners, shampoos, and ayurvedic capsules under the Kesh King brand; brightening creams, and brightening and oil clear face washes for men under the Smart And Handsome brand; balms under the Mentho Plus brand; hair oils under the Emami 7 Oils in One brand; prickly heat powders under the Dermicool brand; moisturising creams and body lotions under the Creme 21 brand; deodorants, eau de toilettes, shampoos, face washes, and shower gels under the HE brand; and body sprays and perfumes, beard and shaving products, body and hair care products, face washes, gift sets, and tools and accessories under The Man Company brand. In addition, the company offers face serums, oil shots, powder face washes, and hair and pure oils under the Brillare brand; hair colors under the Emami Diamond Shine brand; talc under the Emami Golden Beauty brand; herbal fairness cream under the Emami Naturally Fair brand; cold cream under the Emami Malai Kesar Cold Cream brand; and deep moisturizing cream under the Emami Pure Glow brand. Emami Limited was founded in 1974 and is headquartered in Kolkata, India.

Visit company website →
P/E (TTM)
22.5
Forward 18.4
Earnings Growth (YoY)
-11.8%
Revenue -3.9%
ROE
+27.6%
Profit margin +20.5%
Dividend Yield
2.97%
P/B 6.0
vs 52W High
-32.9%
₹384.8 lo₹614.4 hi
32.9% below 52W high — ongoing decline
In Stage 4, distance from the 52W high reflects ongoing decline — not a discount. Avoid catching falling knives.
Stage Maturity
Week 41
1w13w26w
Week 41 — extended decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure — there's no 'bottom' time to buy.
vs 200 DMA
-10.4%
200 DMA: ₹460.3 · sloping down
In Stage 4, the stock is below its 200 DMA — the hallmark of a downtrend. No long positions warranted until this reverses structurally.
Rel Volume
1.53x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low volume bounces are typical — they lack real buyers and should not be mistaken for reversals.
Trend Health
MA20 rolling over · -1.1% vs MA50 -2.3%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Consumer Staples
↓ Peaking
Stage 2%
23.0%
20d Δ
-10.1pp
1M return
+0.5%
3M return
-1.9%
Sector Stage-2 % · last 20 days
Sector has 34 Stage 2 leaders. See Consumer Staples Stage 2 →
Industry
FMCG - Personal Products
→ Flat
Stage 2%
36.4%
20d Δ
+0.0pp
1M return
-0.8%
3M return
+4.4%
Industry Stage-2 % · last 20 days
Industry has 4 Stage 2 leaders. See FMCG - Personal Products Stage 2 →
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-15 → 2026-08-07
S2 15w
S2 18w
S4 15w
S4 42w
2023-05-152026-08-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 2w → S1 9w → S2 15w → S3 7w → S2 6w → S3 5w → S4 8w → S1 3w → S2 18w → S3 11w → S4 15w → S1 11w → S4 8w → S1 1w → S2 5w → S3 1w → S4 42w current
Total tracked: 168 weeks across 17 stage runs.
1M
-0.6%
3M
-9.7%
6M
-13.5%
YTD
-21.6%
1Y
-25.6%
Scan Membership
Breakout Watch
Latest: 2025-09-05
3 appearances in last 60 days. First seen: 2024-01-05.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-07S4
Wk 41 · Vol x
2026-08-06S4
Wk 41 · Vol x
2026-08-05S4
Wk 40 · Vol x
2026-08-04S4
Wk 40 · Vol x
2026-08-03S4
Wk 40 · Vol x
2026-07-31S4
Wk 40 · Vol x
2026-07-30S4
Wk 40 · Vol x
2026-07-29S4
Wk 39 · Vol x
2026-07-28S4
Wk 39 · Vol x
2026-07-27S4
Wk 39 · Vol x
2026-07-24S4
Wk 39 · Vol x
2026-07-23S4
Wk 39 · Vol x
Sector Peers — Stage 2All →
SCPL
wk 26 · -1.3% from hi
8.4
AVADHSUGAR
wk 15 · -2.3% from hi
8.3
CUPID
wk 16 · -0.2% from hi
7.9
BALRAMCHIN
wk 14 · -3.8% from hi
7.9
PICCADIL
wk 4 · -5.3% from hi
7.8
Moving averages & range
50 DMA
₹404.7
200 DMA
₹460.3
52W High
₹614.4
52W Low
₹384.8
5D Low
₹391.8
Resistance levels (recent highs)
20d High
₹427.3
60d High
₹435.1
120d High
₹500.9
250d High
₹614.4
Next resistance
+3.6%
to 20d High

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.